From stem cells to viable autologous semilunar heart valve

Circulation

Volumn 111, Issue 21, 2005, Pages 2783-2791

  Sutherland, Fraser W H ^a,c,e   Perry, Tjorvi E ^a,c   Yu, Ying ^a,c   Sherwood, Megan C ^a,c   Rabkin, Elena ^f   Masuda, Yutaka ^a,c   Garcia, G Alejandra ^a,c   McLellan, Dawn L ^a,c   Engelmayr Jr , George C ^d   Sacks, Michael S ^d   Schoen, Frederick J ^b,c   Mayer, John E ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d University of Pittsburgh   (United States)

^e WESTERN INFIRMARY   (United Kingdom)

^f NONE

Author keywords

Stem cells; Tissue engineering; Valves

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ANTIGEN EXPRESSION; ARTICLE; BIODEGRADABILITY; BIOPROSTHESIS; BONE MARROW CELL; CARDIOPULMONARY BYPASS; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXPLANT; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FOLLOW UP; HEART VALVE; HEART VALVE REPLACEMENT; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; MORBIDITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULMONARY VALVE; SHEEP; STEM CELL; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; CELL DIFFERENTIATION; CELL LINEAGE; ECHOCARDIOGRAPHY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; PLURIPOTENT STEM CELLS; PULMONARY VALVE; SHEEP; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS;

EID: 20344391403     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.498378     Document Type: Article

References (45)

1. Schoen FJ. Pathology of heart valve substitution with mechanical and tissue prostheses. In: Silver MD, Gotlieb AI, Schoen FJ, eds. Cardiovascular Pathology. New York. NY: WB Saunders: 2001:629-677.
2. Dalrymple-Hay MJ, Pearce RK, Dawkins S, Alexiou C, Haw MP, Livesey SA, Monro JL. Mid-term results with 1,503 CarboMedics mechanical valve implants. J Heart Valve Dis. 2000;9:389-395.
3. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives: Providence, RT, April 28-May 2, 1999: tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47:439-465.
4. Perron J, Moran AM, Gauvreau K, del Nido PJ, Mayer JE Jr, Jonas RA. Valved homograft conduit repair of the right heart in early infancy. Ann Thorac Surg. 1999;68:542-548.
5. McLaren A. Ethical and social considerations of stem cell research. Nature. 2001;414:129-131.
6. Korbling M, Estrov Z. Adult stem cells for tissue repair: a new therapeutic concept? N Engl J Med. 2003;349:570-582.
7. Phinney DG. Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl. 2002;38:7-12.
8. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003;101:2999-3001.
9. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E. Tissue engineering of cardiac valve prostheses, I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis. 2002;11:457-462.
10. Teebken O, Mertsching H, Haverich A. Modification of heart valve allografts and xenografts by means of tissue engineering. Transplant Proc. 2002;34:2333.
11. Schenke-Layland K, Opitz F, Gross M, Doring C, Halbhuber KJ, Schirrmeister F, Wahlers T, Stock UA. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals: an in vitro study. Cardiovasc Res. 2003;60:497-509.
12. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284: 143-147.
13. Gloeckner DC, Billiar KL, Sacks MS. Effects of mechanical fatigue on the bending properties of the porcine bioprosthetic heart valve. Asaio J. 1999;45:59-63.
14. Messier RH, Jr., Bass BL, Aly HM, Jones JL, Domkowski PW, Wallace RB, Hopkins RA. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res. 1994;57:1-21.
15. Chafizadeh ER, Zoghbi WA. Doppler echocardiographic assessment of the St. Jude Medical prosthetic valve in the aortic position using the continuity equation. Circulation. 1991;83:213-223.
16. Milano AD, De Carlo M, Mecozzi G, D'Alfonso A, Scioti G, Nardi C, Bortolotti U. Clinical outcome in patients with 19-mm and 21-mm St. Jude aortic prostheses: comparison at long-term follow-up. Ann Thorac Surg. 2002;73:37-43.
17. Cosgrove DM, Lytle BW, Williams GW. Hemodynamic performance of the Carpentier-Edwards pericardial valve in the aortic position in vivo. Circulation. 1985;72(suppl II):II-146-II-152.
18. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418: 41-49.
19. Sutherland FW, Mayer JE Jr. Ethical and regulatory issues concerning engineered tissues for congenital heart repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2003;6:152-163.
20. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-926.
21. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995;60: S513-S516.
22. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102(suppl III):III-44-III-9.
23. Peltoniemi HH, Hallikainen D, Toivonen T, Helevirta P, Waris T. SR-PLLA and SR-PGA miniscrews: biodegradation and tissue reactions in the calvarium and dura mater. J Craniomaxillofac Surg. 1999;27: 42-50.
24. Vesely I, Boughner D. Analysis of the bending behaviour of porcine xenograft leaflets and of neutral aortic valve material: bending stiffness, neutral axis and shear measurements. J Biomech. 1989;22:655-671.
25. Taylor MS, Daniels AU, Andriano KP, Heller J. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater. 1994;5:151-157.
26. Bostman OM, Paivarinta U, Partio E et al. The tissue-implant interface during degradation of absorbable polyglycolide fracture fixation screws in the rabbit femur. Clin Orthop. 1992;Dec:263-272.
27. Beck A, Thubrikar MJ, Robicsek F. Stress analysis of the aortic valve with and without the sinuses of Valsalva. J Heart Valve Dis. 2001; 10:1-11.
28. Grande-Allen KJ, Cochran RP, Reinhall PG, Kunzelman KS. Finite-element analysis of aortic valve-sparing: influence of graft shape and stiffness. IEEE Trans Biomed Eng. 2001;48:647-659.
29. Thubrikar MJ, Skinner JR, Eppink RT, Nolan SP. Stress analysis of porcine bioprosthetie heart valves in vivo. J Biomed Mater Res. 1982; 16:811-826.
30. Engelmayr GC Jr, Hildebrand DK, Sutherland FW, Mayer JE Jr, Sacks MS. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials. 2003;24:2523-2532.
31. Della Rocca F, Sartore S, Guidolin D, Bertiplaglia B, Gerosa G, Casarotto D, Pauletto P. Cell composition of the human pulmonary valve: a comparative study with the aortic valve: the VESALIO Project: Vitalitate Exornatum Succedaneum Aorticum labore Ingegnoso Obtinebitur. Ann Thorac Surg. 2000;70:1594-1600.
32. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA. 1996;93:4219-4223.
33. Vogel G. Stem cell research: studies cast doubt on plasticity of adult cells. Science. 2002;295:1989-1991.
34. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002; 416:542-545.
35. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 2002;416:545-548.
36. Wever RM, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998;97: 108-112.
37. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16:523-532.
38. Mitehell RN, Jonas RA, Schoen FJ. Pathology of explained cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg. 1998;115:118-127.
39. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatterman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1991;275:964-961.
40. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712.
41. Paranya G, Vineberg S, Dvorin E, Kaushal S, Roth SJ, Rabkin E, Schoen FJ, Bischoff J. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol. 2001;159: 1335-1343.
42. Kaviani A, Guleserian K, Perry TE, Jennings RW, Ziegler MM, Fauza DO. Fetal tissue engineering from amniotic fluid. J Am Coll Surg. 2003; 196:592-597.
43. Kaviani A, Perry TE, Barnes CM, Oh JT, Ziegler MM, Fishman SJ, Fauza DO. The placenta as a cell source in fetal tissue engineering. J Pediatr Surg. 2002;37:995-999.
44. Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE, Masuda Y, Sutherland FW, Schoen FJ, Mayer JE Jr, Bischoff J. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2004;287: H480-H487.
45. Maish MS, Hoffman-Kim D, Krueger PM, Souza JM, Harper JJ 3rd, Hopkins RA. Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves. J Heart Valve Dis. 2003;12:264-269.